Antineoplastic Agents, Hormonal

DBCAT000063Pharmacologic class

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A DrugBank category of 32 drugs. 29 of them are approved.

Also known as: Agents, Antineoplastic Hormonal · Antineoplastic Drugs, Hormonal · Antineoplastic Hormonal Agents · Antineoplastic Hormonal Drugs · Antineoplastics, Hormonal
Drugs: Aminoglutethimide
Anastrozole
Camizestrant
Chlorotrianisene
Dexamethasone
Dienogest
Diethylstilbestrol
Estramustine
Estramustine phosphate
Fadrozole
Flutamide
Fulvestrant
Goserelin
Hexestrol
Leuprolide
Liarozole
Medroxyprogesterone acetate
Megestrol
Megestrol acetate
Methylprednisolone hemisuccinate
Methyltestosterone
Mitotane
Nafoxidine
Octreotide
Prednisolone
and 7 more with a free account

What you can answer from here — as of August 24, 2016

32DrugsEach linked to its full drug card

41Drug targetsEvery drug–target pair in the class, with bond type

6,047Marketed productsAcross the regions we cover, with dosage forms and routes

31Routes of administrationHow the drugs in this class are given

Which targets do Antineoplastic Agents, Hormonal share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account